Compare how Sanofi describes Influenza and Respiratory Syncytial Virus (RSV) on their U.S. website. For each, identify who is primarily affected, what protective measures are highlighted, and the general impact or severity mentioned. Summarize the key differences.
Navigate to the 'Your Health' section on sanofi.com. From the 'Your Health' menu, navigate to the 'Influenza' page under 'Vaccines'. Extract the primary affected population, highlighted protective measure, and general impact/severity for Influenza. Return to the main navigation menu. From the 'Your Health' menu, navigate to the 'Respiratory Syncytial Virus' page under 'Vaccines'. Extract the primary affected population, highlighted protective measure, and general impact/severity for RSV. Synthesize and present a comparative summary of the information for both diseases.
Successfully navigate to both the 'Influenza' and 'Respiratory Syncytial Virus' pages. For Influenza, state that it impacts 'people around the world,' the best protective measure is an 'annual flu vaccination,' and it leads to 'thousands of flu-related complications, hospitalizations, and deaths each year.' For Respiratory Syncytial Virus (RSV), state that it primarily targets 'babies,' emphasizes 'RSV prevention is awareness' and providing 'families... with resources and information' as protective measures, and causes 'serious lung infection.' Clearly present a comparative summary of the information for both diseases.